Atlas Trials

Recurrent Small Cell Lung Carcinoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Small Cell Lung Carcinoma

RecordFirmDate
Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer (NCT03728361)Dwight Owen2018-12-31
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer (NCT02701400)Emory University2016-04-14
Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer (NCT02351505)Erin Bertino2015-05-01
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer (NCT01737502)Mayo Clinic2014-05-14
Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer (NCT01876446)Roswell Park Cancer Institute2013-08-29
Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer (NCT01533181)National Cancer Institute (NCI)2012-02-01
A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage (NCT00887159)National Cancer Institute (NCI)2009-07-16
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer (NCT00856037)University of Nebraska2009-02-02

Track Recurrent Small Cell Lung Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.